Onconetix, Inc. (ONCO)
0.9962
+0.26
(+34.80%)
USD |
NASDAQ |
Sep 04, 16:00
0.813
-0.18
(-18.39%)
After-Hours: 20:00
Onconetix Net Income (Annual) : -14.03M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -14.03M |
| December 31, 2024 | -58.69M |
| December 31, 2023 | -37.41M |
| December 31, 2022 | -13.42M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.417M |
| December 31, 2020 | -1.600M |
| December 31, 2019 | -0.8219M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Aprea Therapeutics, Inc. | -12.60M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |